Open access to large scale datasets is needed to translate knowledge of cancer heterogeneity into better patient outcomes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25710538.
- Also identified by DOI 10.1371/journal.pmed.1001794 and PMC identifier 4339838.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this guest editorial, Andrew Beck discusses the importance of open access to big data for translating knowledge of cancer heterogeneity into better outcomes for cancer patients.
Medical subject headings
- Access to Information
- Databases, Factual
- Genetic Variation
- Health Services Needs and Demand
- Molecular Targeted Therapy
- Neoplasms
- Translational Research, Biomedical